Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 6;40(16):2442-2456.
doi: 10.1016/j.vaccine.2022.02.085. Epub 2022 Mar 3.

COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France

Pierre-Julien Coulaud  1 , Aidan Ablona  2 , Naseeb Bolduc  3 , Danya Fast  4 , Karine Bertrand  5 , Jeremy K Ward  6 , Devon Greyson  7 , Marie Jauffret-Roustide  8 , Rod Knight  4
Affiliations

COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France

Pierre-Julien Coulaud et al. Vaccine. .

Abstract

Background: High rates of COVID-19 vaccination uptake are required to attain community immunity. This study aims to identify factors associated with COVID-19 vaccine uncertainty and refusal among young adults, an underexplored population with regards to vaccine intention generally, in two high-income settings: Canada and France.

Methods: A cross-sectional online survey was conducted from October to December 2020 among young adults ages 18-29 years (n = 6663) living in Canada (51.9%) and France (48.1%). Multinomial logistic regression analyses were performed to identify the sociodemographic and COVID-19-related measures (e.g., prevention behavior and perspectives, health-related concerns) associated with vaccine uncertainty and refusal. We conducted weighted analyses by age, gender and province/region of residence.

Results: Intention to accept vaccination was reported by 84.3% and 59.7% of the sample in Canada and France, respectively. Higher levels of vaccine uncertainty and refusal were observed in France compared to Canada (30.1% versus 11%, 10.2% versus 4.7%). In both countries, we found higher levels of vaccine acceptance among young adults who reported COVID-19 prevention actions. Vaccine uncertainty and refusal were associated with living in a rural area, having lower levels of educational attainment, not looking for information about COVID-19, not wearing a face mask, and reporting a lower level of concern for COVID-19's impact on family. Participants who had been tested for COVID-19 were less likely to intend to refuse a vaccine.

Conclusions: COVID-19 vaccine acceptance was high among young adults in Canada and France during a time in which vaccines were approved for use. Targeted interventions to build confidence in demographic groups with greater hesitance (e.g., rural and with less personal experience with COVID-19) may further boost acceptance and improve equity as vaccine efforts continue to unfold.

Keywords: COVID-19; Preventive measures; Vaccination; Young adults.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
COVID-19 prevention actions in vaccine intention groups.
See this image and copyright information in PMC

References

    1. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403–416. - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603–2615. - PMC - PubMed
    1. Moderna COVID-19 Vaccine | FDA [Internet]. [cited 2021 Feb 15]. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-dise....
    1. Pfizer-BioNTech COVID-19 Vaccine | FDA [Internet]. [cited 2021 Feb 15]. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-dise....
    1. Weekes M., Jones N.K., Rivett L., Workman C., Ferris M., Shaw A., et al. Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. Authorea Prepr. 2021 Feb 24. - PMC - PubMed

Publication types

Substances

Grants and funding